Protocol: ADA Bridging ELISA For Use With Anti-Infliximab Antibody
Anti-Drug Antibody (ADA) Bridging ELISA: For use with anti-infliximab monoclonal antibody product HCA213
This method provides a procedure for generating an ADA ELISA standard curve with anti-infliximab antibody, product code HCA213, using infliximab antibody for capture and detection. The method should always be used in conjunction with product and batch specific information provided with each vial (see product datasheets). This protocol will need to be adjusted for use with different detection methods and immunoassay technology platforms.
View all of our infliximab antibodies
MaxiSorp™ and QuantaBlu™ are trademarks of Thermo Fisher Scientific.
Tween® is a registered trademark of ICI Americas Inc.